tiprankstipranks
Trending News
More News >
Biotage AB (SE:BIOT)
:BIOT

Biotage AB (BIOT) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Biotage AB has a market cap or net worth of $11.40B. The enterprise value is ―.
Market Cap$11.40B
Enterprise Value

Share Statistics

Biotage AB has 80,049,270 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding80,049,270
Owned by Insiders
Owned by Institutions

Financial Efficiency

Biotage AB’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 7.28%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)7.28%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee3.31M
Profits Per Employee527.33K
Employee Count622
Asset Turnover0.40
Inventory Turnover1.67

Valuation Ratios

The current PE Ratio of Biotage AB is 45.31. Biotage AB’s PEG ratio is -4.35.
PE Ratio45.31
PS Ratio0.00
PB Ratio2.93
Price to Fair Value3.13
Price to FCF59.19
Price to Operating Cash Flow32.34
PEG Ratio-4.35

Income Statement

In the last 12 months, Biotage AB had revenue of 2.06B and earned 284.00M in profits. Earnings per share was 3.55.
Revenue2.06B
Gross Profit1.29B
Operating Income383.00M
Pretax Income328.00M
Net Income284.00M
EBITDA568.00M
Earnings Per Share (EPS)3.55

Cash Flow

In the last 12 months, operating cash flow was 348.00M and capital expenditures -160.00M, giving a free cash flow of 188.00M billion.
Operating Cash Flow348.00M
Free Cash Flow188.00M
Free Cash Flow per Share2.35

Dividends & Yields

Biotage AB pays an annual dividend of kr1.649, resulting in a dividend yield of 1.04%
Dividend Per Sharekr1.649
Dividend Yield1.04%
Payout Ratio47.25%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.05
52-Week Price Change-17.18%
50-Day Moving Average122.69
200-Day Moving Average145.80
Relative Strength Index (RSI)77.00
Average Volume (3m)874.23K

Important Dates

Biotage AB upcoming earnings date is Jul 16, 2025, TBA Not Confirmed.
Last Earnings DateApr 23, 2025
Next Earnings DateJul 16, 2025
Ex-Dividend DateApr 25, 2025

Financial Position

Biotage AB as a current ratio of 2.33, with Debt / Equity ratio of 6.19%
Current Ratio2.33
Quick Ratio1.55
Debt to Market Cap0.01
Net Debt to EBITDA-0.32
Interest Coverage Ratio22.53

Taxes

In the past 12 months, Biotage AB has paid 44.00M in taxes.
Income Tax44.00M
Effective Tax Rate0.13

Enterprise Valuation

Biotage AB EV to EBITDA ratio is 22.33, with an EV/FCF ratio of 51.99.
EV to Sales6.17
EV to EBITDA22.33
EV to Free Cash Flow51.99
EV to Operating Cash Flow30.71

Balance Sheet

Biotage AB has $420.00M in cash and marketable securities with kr238.00M in debt, giving a net cash position of -$182.00M billion.
Cash & Marketable Securities$420.00M
Total Debtkr238.00M
Net Cash-$182.00M
Net Cash Per Share-$2.27
Tangible Book Value Per Share$9.81

Margins

Gross margin is 62.67%, with operating margin of 18.63%, and net profit margin of 13.81%.
Gross Margin62.67%
Operating Margin18.63%
Pretax Margin15.95%
Net Profit Margin13.81%
EBITDA Margin27.63%
EBIT Margin18.63%

Analyst Forecast

The average price target for Biotage AB is $143.02, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$143.02
Price Target Upside0.37% Upside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast-1.01%
EPS Growth Forecast6.10%

Scores

Smart ScoreN/A
AI Score71.75
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis